top of page

Dr Michael McCoy

Michael obtained his MChem from the University of Bath in 2017. He completed his third-year research project on the development of benzothiophene antibiotics to treat malaria.

The following summer, he undertook research under the supervision of Dr. Simon Lewis on functionalisation of novel rearrangement products. Michael stayed within the Lewis group, completing his master’s research on photochemical dearomative dihydroxylations. Furthermore, Michael was appointed lead peer mentor in the chemistry department during his final year.

Michael’s Ph.D is focused on the identification & development of novel Wnt/β-catenin signalling inhibitors. At the interface of chemical biology, this research couples biophysical screening techniques (DSF, NMR, ITC, in silico) to identify novel inhibitors, which may be developed using modern medicinal chemistry approaches.


bottom of page